Glucocorticoid use in rheumatoid arthritis patients and the onset of pneumonia: a systematic review and meta-analysis.
Kawther N ElsouriVania ArboledaLynn BasbousSamantha HeiserDylon P CollinsPhilip RagusaCourney BaxterDominick CabreraTanisha AkhandEvan StermerKiran SharmaCharmaine SeguroPatrick HardiganMarc KesselmanMichelle Demory BecklerPublished in: Journal of osteopathic medicine (2023)
Our data suggest that RA patients have a higher probability of developing pneumonia on combination therapy with GCs, compared to monotherapy with DMARDs. To our knowledge, our findings are the first to systematically review and statistically evaluate the relationship between the use of GCs and show an increased chance of developing pneumonia.
Keyphrases
- combination therapy
- rheumatoid arthritis patients
- disease activity
- end stage renal disease
- ejection fraction
- rheumatoid arthritis
- newly diagnosed
- chronic kidney disease
- systemic lupus erythematosus
- prognostic factors
- peritoneal dialysis
- electronic health record
- randomized controlled trial
- clinical trial
- patient reported outcomes
- patient reported
- idiopathic pulmonary fibrosis
- double blind